Comparison of the Fatal Toxicity Index of Zopiclone with Benzodiazepines

Journal of Toxicology - Clinical Toxicology

Volumn 41, Issue 7, 2003, Pages 975-980

  Reith, David M ^a,d   Fountain, John ^b   McDowell, Rebecca ^c   Tilyard, Murray ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^d DUNEDIN HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBON MONOXIDE; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; CLONAZEPAM; DEXTROPROPOXYPHENE; DIAMORPHINE; DIAZEPAM; DOSULEPIN; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; LORMETAZEPAM; METHADONE; MIDAZOLAM; MORPHINE; NITRAZEPAM; OXAZEPAM; PARACETAMOL; PHENOBARBITAL; SEDATIVE AGENT; TEMAZEPAM; TRIAZOLAM; ZOPICLONE;

ARTICLE; DRUG FATALITY; DRUG INTOXICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PRESCRIPTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; HUMANS; HYPNOTICS AND SEDATIVES; MIDDLE AGED; NEW ZEALAND; PIPERAZINES; POISONING; PRESCRIPTIONS, DRUG;

EID: 0346734259     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120026520     Document Type: Article

References (31)

1. Mendelson WB, Jain B. An assessment of shortacting hypnotics. Drug Saf 1995; 13(4):257-270.
2. Goa KL, Heel RC. Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1986; 32(1):48-65.
3. Boniface PJ, Martin IC, Nolan SL, Tan ST. Development of a method for the determination of zopiclone in whole blood. J Chromatogr 1992; 584(2):199-206.
4. Boniface PJ, Russell SG. Two cases of fatal zopiclone overdose. J Anal Toxicol 1996; 20(2):131-133.
5. Pounder DJ, Davies JL. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. Forensic Sci Int 1994; 65(3):177-183.
6. Meatherall RC. Zopiclone fatality in a hospitalised patient. J Forensic Sci 1997; 42(2):340-343.
7. Bramness JG, Arnestad M, Karinen R, Hilberg T. Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma. J Forensic Sci 2001; 46(5):1247-1249.
8. Shah R, Uren Z, Baker A, Majeed A. Trends in deaths from drug overdose and poisoning in England and Wales 1993-1998. J Public Health Med 2001; 23(3):242-246.
9. Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Correlations between prescriptions and drugs taken in self-poisoning. Implications for prescribers and drug regulation. Med J Aust 1995; 162(4):194-197.
10. Buckley NA, Dawson AH, Whyte IM, O'Connell DL. Relative toxicity of benzodiazepines in overdose. BMJ 1995; 310:219-221.
11. Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993; 163:386-393.
12. Drummer OH, Ranson DL. Sudden death and benzodiazepines. Amer J Foren Med Path 1996; 95(4):283-287.
13. Verstraete AG, Buylaert WA, Blondeel L. Use of benzodiazepines in the general population and their involvement in acute self-poisoning cases. Pharmacoepidemiol Drug Saf 1998; 7(6):403-410.
14. Sundquist J, Ekedahl A, Johansson S-E. Sales of tranquillizers, hypnotics/sedatives and antidepressants and their relationship with underprivileged area score and mortality and suicide rates. Eur J Clin Pharmacol 1996; 51(2):105-109.
15. Stata C. STATA for Windows. In. 6.0 ed. College Station, TX 77840: Stata Corporation, 1999.
16. Capella D. Descriptive tools and analysis. In: Dukes MNG, ed. Drug Utilization Studies: Methods and Uses: World Health Organization, 1993:55-78.
17. Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002; 325:1332-1333.
18. Marriott S, Tyrer P. Benzodiazepine dependence. Avoidance and withdrawal. Drug Saf 1993; 9(2):93-103.
19. Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002; 97(1):39-47.
20. Jonas JM, Hearron AE. Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. J Clin Psychopharmacol 1996; 16(3):208-211.
21. Isbister GK, O'Regan L, Sibbritt D, Whyte IM. Alprazolam is relatively more toxic than other benzodiazepines in overdose. J Toxicol Clin Toxicol 2003; 41(5):(In press).
22. Williams D, McBride AJ. The drug treatment of alcohol withdrawal symptoms: a systematic review. Alcohol Alcoholism 1998; 33(2):103-115.
23. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162(2):225-233.
24. Musch B, Maillard F. Zopiclone, the third generation hypnotic: a clinical overview. Int Clin Psychopharmacol 1990; 5(Suppl 2):147-158.
25. Delahaye C, Ferrand B, Pieddeloup C, Musch B. Post marketing surveillance of zopiclone: interim analysis on the first 10,000 cases in a clinical study in general practice. Int Clin Psychopharmacol 1990; 5(Suppl 2):131-138.
26. Wagner J, Wagner ML, Hening WA. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 1998; 32(6):680-691.
27. Hajak G. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience. Drug Saf 1999; 21(6):457-469.
28. Buckley NA, McManus PR. The fatal toxicity index (FT1) of anxiolytic and sedative drugs in the UK (1983-1999). J Toxicol Clin Toxicol 2002; 40:344.
29. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ 2000; 162(2):216-220.
30. Ekeberg O, Jacobsen D, Flaaten B, Mack A. Effect of regulatory withdrawal of drugs and prescription recommenations on the pattern of self-poisonings in Oslo. Acta Med Scand 1987; 221:483-487.
31. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999; 94(7):961-972.